Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells
Hongmei Mou(Massachusetts General Hospital), Jayaraj Rajagopal(Massachusetts General Hospital), Allen Lapey(Boston Children's Hospital), Jan Harrington(Cystic Fibrosis Foundation), John F. Engelhardt(University of Iowa), Adam Freund(University of California, Berkeley), Colleen Keyes(Massachusetts General Hospital), Steven E. Artandi(Stanford University), Adrianne K. Crooke(University of Iowa), Steven M. Rowe(University of Alabama at Birmingham), Brett Turner(University of Alabama at Birmingham), Martin Mense(Cystic Fibrosis Foundation), Karissa Brazauskas(Boston Children's Hospital), George M. Solomon(University of Alabama), Hermann Bihler(Cystic Fibrosis Foundation), Ya‐Chieh Hsu(Harvard University), Soon Ho Choi(University of Iowa), Purushothama Rao Tata(Duke University), Bing Zhang(Baylor Genetics), Vladimir Vinarsky(Massachusetts General Hospital), Colleen L. Channick(Massachusetts General Hospital)
Cited by 409
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k